European Society of Toxicology In Vitro > News > Non-animal Methods in Science and Regulation
8 February 2021

Non-animal Methods in Science and Regulation

The annual EURL ECVAM status report describes research, development and validation activities, as well as initiatives that promote the regulatory use and international adoption of non-animal methods and approaches and their dissemination in the regulatory and research arenas. EU policies and legislation call for innovative and more efficient ways of safety testing and chemical risk assessment that do not depend on animal testing. Advanced technologies such as computational models, in vitro methods and organ-on-chip devices are being developed, evaluated and integrated to translate mechanistic understanding of toxicity into safety testing strategies. The ultimate goal is to achieve better protection of human health and the environment while supporting EU innovation and industrial competitiveness, without the use of animals. The development and use of non-animal models and methods are also essential for advancing basic, applied and translational research. Education also plays an essential role in enabling a shift to non-animal methods through the introduction of the Three Rs (Replacement, Reduction and Refinement of animal use in science) into secondary school curricula and programmes of higher education.

More information at: https://ec.europa.eu/jrc/en/publication/eur-scientific-and-technical-research-reports/non-animal-methods-science-and-regulation

Related content

Celebrating Talents in Toxicology: ESTIV Awards at ASCCT 2024

We are thrilled to announce the recipients of the ESTIV Awards recognizing outstanding early-career scientists at last week’s ASCCT Congress

ASCCT-ESTIV Award Winners Series: Dr. Eliska Kuchovska & Tiago Marques Pedro

  • News

Registration is open for the next joint ASCCT-ESTIV webinar featuring two excellent early career scientists and award recipients

Welcoming Luiz Ladeira to the ESTIV Board!

  • News

We are excited to announce that Dr. Luiz Ladeira has joined the ESTIV Board! Luiz brings exceptional expertise in physiological maps and AOP research, and a strong commitment to advancing in vitro and in silico toxicology.

Silver Sponsor

Memorandum of Understanding